Life Science

Kymera to Relocate to Biotech Cluster

Watertown, MA – Boylston Properties announced that Kymera Therapeutics has signed a lease for approximately 34,500sf at Arsenal Yards‘ new state-of-the-art life science lab space.

Set within an original 1800s Arsenal historic building, the life science lab space is offering a number of amenities and a private shuttle to the Harvard Square Red Line T stop.

Kymera Therapeutics will relocate from Cambridge to East End Watertown in the first half of 2020. Founded in 2016, it is a biotechnology company pioneering the field of targeted protein degradation, a transformative new approach to develop medicines for diseases with limited or no treatment options.

With initial openings planned for late 2019 and throughout 2020, Arsenal Yards will be a thriving new neighborhood comprised of over 1 million sq. ft. of development by 2021.

The mixed-used development will include 250,000sf of shopping, dining and fitness; a seven-screen cinema, The Majestic at Arsenal Yards; local grocer Roche Bros.; 300 contemporary apartments; and a 146-room Hampton Inn by Hilton.

Life science companies are flocking to Watertown to secure space in the town’s booming biotech scene. Kymera Therapeutics continues this trend, joining SQZ Biotech in moving to Arsenal Yards’ life science lab space. The new development is located across the street from LINX, 185,000sf of currently fully leased lab space, also developed by Boylston Properties.

“Given the state-of-the-art amenities and proximity to life science’s biggest names and talent, Watertown is now a first choice for life science companies,” said Bill McQuillan, principal of Boylston Properties. “We’re proud to welcome Kymera Therapeutics to the Watertown life science cluster and look forward to supporting their continued growth. We are thankful to have worked alongside the great commercial real estate professionals at Cushman & Wakefield and Newmark to be able to welcome another cutting-edge life science company to Arsenal Yards.”

“Kymera is developing a company for the future. We were interested in a work environment that could grow with us and support our mission, fostering collaboration and productivity as we expand our programs and team. Arsenal Yards checked all of those boxes and has demonstrated a commitment to supporting a thriving and growing life sciences community,” said Nello Mainolfi, PhD, founder, president and chief scientific officer at Kymera Therapeutics. “We’re thrilled to start our next chapter in Watertown.”

Kymera Therapeutics was represented by Juliette Reiter and Mark Winters of Newmark. Boylston Properties was represented by Duncan Gratton and Elizabeth Donatoni of Cushman & Wakefield.

“Boylston Properties is paving the way for a booming life science and healthcare cluster in Watertown with the development of Arsenal Yards, and this is apparent as we’ve now closed deals with eight life science companies in Watertown, totaling approximately 300,000 square feet,” said Duncan Gratton, executive director at Cushman & Wakefield. “Watertown is more than Kendall Square overflow. It’s becoming its own urban neighborhood that attracts top talent with its amenities, proximity to Boston and Cambridge, and its best-in-class life science lab development.”